|
|||||
|
|
A potent and selective natriuretic peptide receptor-3 blocker 11-mer peptide created by hybridization of musclin and atrial natriuretic peptide |
|
| Authors: | Naoki Nishizawa Goshi Nakamura Yoko Noguchi Hideyuki Nakagawa Ayako Shimizu Masaharu Nakayama Shiro Takekawa Taiji Asami |
| Affiliation: | Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, Fujisawa 251-8555, Japan |
| Abstract: | |
| Keywords: | ANP atrial natriuretic peptide Arg(Me) cGMP cyclic guanosine monophosphate Cha 3-cyclohexylalanine GC guanylate cyclase hANP human ANP Hyp LC/MS/MS liquid chromatography–tandem mass spectrometry mANP mutant ANP NPR3 natriuretic peptide receptor-3 PBS phosphate buffered saline Natriuretic peptide receptor-3 Blocker Peptide A-type natriuretic peptide (ANP) Musclin |
| 本文献已被 ScienceDirect 等数据库收录！ | |